Financials data is unavailable for this security.
View more
Year on year Hisamitsu Pharmaceutical Co Inc grew revenues 10.42% from 128.33bn to 141.71bn while net income improved 18.97% from 11.74bn to 13.97bn.
Gross margin | 55.74% |
---|---|
Net profit margin | 10.47% |
Operating margin | 8.33% |
Return on assets | 4.62% |
---|---|
Return on equity | 5.61% |
Return on investment | 5.50% |
More ▼
Cash flow in JPYView more
In 2024, Hisamitsu Pharmaceutical Co Inc did not generate a significant amount of cash. However, the company earned 18.19bn from its operations for a Cash Flow Margin of 12.83%. In addition the company used 2.51bn on investing activities and also paid 16.69bn in financing cash flows.
Cash flow per share | 270.74 |
---|---|
Price/Cash flow per share | 16.12 |
Book value per share | 3,607.43 |
---|---|
Tangible book value per share | 3,517.10 |
More ▼
Balance sheet in JPYView more
Current ratio | 3.50 |
---|---|
Quick ratio | 3.09 |
Total debt/total equity | 0.0043 |
---|---|
Total debt/total capital | 0.0042 |
More ▼
Growth rates in JPY
SmartText is unavailable
Div yield(5 year avg) | 1.93% |
---|---|
Div growth rate (5 year) | 0.60% |
Payout ratio (TTM) | 44.28% |
EPS growth(5 years) | -4.62 |
---|---|
EPS (TTM) vs TTM 1 year ago | 7.48 |
More ▼